These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27117974)

  • 1. A neonate with abdominal distension and failure to thrive.
    Tadiotto E; Maines E; Degani D; Banzato C; Balter R; Gugelmo G; Dardis A; Giordano G; Bordugo A
    Arch Dis Child Educ Pract Ed; 2017 Jun; 102(3):166. PubMed ID: 27117974
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological, biochemical, and genetic characterization of early-onset fulminating sialidosis type 2 in a Korean neonate with hydrops fetalis.
    Lee BH; Kim YM; Kim JH; Kim GH; Lee BS; Kim CJ; Yoo HJ; Yoo HW
    Brain Dev; 2014 Feb; 36(2):171-5. PubMed ID: 23433491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hydrops fetalis as an indication for a systematic investigation into the presence of lysosomal storage diseases].
    Janssens PM; de Groot AN; de Jong JG; Liebrand-van Sambeek ML; Smits A; Wevers RA
    Ned Tijdschr Geneeskd; 2004 Feb; 148(6):264-8. PubMed ID: 15004952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies.
    Kooper AJ; Janssens PM; de Groot AN; Liebrand-van Sambeek ML; van den Berg CJ; Tan-Sindhunata GB; van den Berg PP; Bijlsma EK; Smits AP; Wevers RA
    Clin Chim Acta; 2006 Sep; 371(1-2):176-82. PubMed ID: 16674934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the Next Barriers to Successful Therapy.
    Cohen IJ; Baris H; Mistry PK; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():629. PubMed ID: 27491209
    [No Abstract]   [Full Text] [Related]  

  • 6. Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders.
    Lachmann RH
    Drugs Today (Barc); 2006 Jan; 42(1):29-38. PubMed ID: 16511609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrops fetalis: lysosomal storage disorders in extremis.
    Stone DL; Sidransky E
    Adv Pediatr; 1999; 46():409-40. PubMed ID: 10645471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis.
    Bonduelle M; Lissens W; Goossens A; De Catte L; Foulon W; Denis R; Jauniaux E; Liebaers I
    Genet Couns; 1991; 2(4):227-32. PubMed ID: 1799421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal disorders.
    Wraith JE
    Semin Neonatol; 2002 Feb; 7(1):75-83. PubMed ID: 12069540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypernatraemic dehydration in collodion baby].
    Magid T; Fenger-Grøn J; Nymann P; Hansen BM
    Ugeskr Laeger; 2007 Mar; 169(13):1232-3. PubMed ID: 17425931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis.
    Gort L; Granell MR; Fernández G; Carreto P; Sanchez A; Coll MJ
    Prenat Diagn; 2012 Dec; 32(12):1139-42. PubMed ID: 22991067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic liver disease.
    McKiernan P
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):287-90. PubMed ID: 22521124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases.
    Tifft CJ; Proia RL
    Glycobiology; 2000 Dec; 10(12):1249-58. PubMed ID: 11159916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of infantile free sialic acid storage disease.
    Lemyre E; Russo P; Melançon SB; Gagné R; Potier M; Lambert M
    Am J Med Genet; 1999 Feb; 82(5):385-91. PubMed ID: 10069709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice.
    Kaidonis X; Byers S; Ranieri E; Sharp P; Fletcher J; Derrick-Roberts A
    Mol Genet Metab; 2016 Jun; 118(2):100-10. PubMed ID: 27106513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease: improving management.
    Bembi B; Deegan P
    Acta Paediatr; 2008 Apr; 97(457):81-2. PubMed ID: 18339194
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate reduction therapy.
    Platt FM; Jeyakumar M
    Acta Paediatr; 2008 Apr; 97(457):88-93. PubMed ID: 18339196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful intrauterine treatment of a supraventricular tachycardia-induced hydrops fetalis with digoxin and verapamil].
    Schwingshandl J; Stein JI; Häusler M
    Wien Klin Wochenschr; 1991; 103(3):73-4. PubMed ID: 2028615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvement.
    Pastores GM
    Recent Pat CNS Drug Discov; 2006 Jan; 1(1):77-82. PubMed ID: 18221193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Niemann-Pick diseases in adults].
    Sedel F
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S292-3. PubMed ID: 17961863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.